Description
Product Description:
Regorafenib is an oral multi-kinase inhibitor involved in normal cellular functioning and in pathological processes such as oncogenesis, tumor angiogenesis, metastasis, and tumor immunity.It is used in the therapy of metastatic colorectal cancer , gastrointestinal stromal tumor and hepatocellular carcinoma (HCC) who have been previously treated with Sorafenib.
Product Features:
| Product Name | : Regonix |
| Generic Name | :Regorafenib |
| Formulation | : Tablet |
| Available size | : 28’s |
| Strengths | : 40mg |
| Registrations | : Available |
Reviews
There are no reviews yet.